Skip to main content
Equibles

Catherine Bonuccelli

Board Member

Quince Therapeutics, Inc. (QNCX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Catherine Bonuccelli

Catherine Bonuccelli is recorded as Board Member at Quince Therapeutics, Inc. (QNCX). Quince Therapeutics, Inc. reported in an 8-K filed October 9, 2026 that Catherine Bonuccelli was appointed Director. Quince Therapeutics, Inc. reported in an 8-K filed October 2, 2026 that Catherine Bonuccelli was appointed Class I director.

“IRulya is strengthening its Board of Directors with the following appointments:”
Quince Therapeutics, Inc. Form 8-K, filed October 9, 2026 · Read the filing
“on October 1, 2026, the Board approved the conditional appointments of each of Catherine Bonuccelli, Leone Patterson, James Valentine and Drayton Wise (collectively, the “Incoming Directors”) to the Board, effective as of the Effective Time.”
Quince Therapeutics, Inc. Form 8-K, filed October 2, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Quince Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.